TIFFANY RANEY: Open Payments
NPI 1497483804 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 28 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 11 | $261 |
| Merz Pharmaceuticals, LLC | 3 | $121 |
| Teva Pharmaceuticals USA, Inc. | 3 | $90 |
| ABBVIE INC. | 3 | $71 |
| Ipsen Biopharmaceuticals, Inc | 2 | $64 |
| Neurocrine BioSciences, Inc. | 1 | $39 |
| ACADIA Pharmaceuticals Inc | 1 | $28 |
| Biogen, Inc. | 1 | $26 |
| Amgen Inc. | 1 | $23 |
| Cala Health, Inc. | 1 | $20 |
Products named: Bionic Navigator, General - DBS, Xeomin, Dysport, AUSTEDO XR, INBRIJA, INGREZZA, AJOVY.
Industry payments across WA — which companies pay providers there.
